Conventional influenza vaccination compared to MF59 adjuvanted subunit vaccine

被引：0
|
作者：
Torrecilla Rojas, Maria Amparo [1 ]
Pedregal Gonzalez, Miguel [2 ]
Garcia Rodriguez, Fermin [3 ]
Ruiz Fernandez, Josefa [3 ]
机构：
[1] Unidad Salud Publ, Dist Sanitario Condado C, Huelva, Spain
[2] Unidad Docente Med Familiar & Comunitaria, Dist Sanitario Huelva Co, Huelva, Spain
[3] Consejeria Salud Junta Andalucia, Secretaria Gen Salud Publ & Participac, Seville, Spain
来源：
ATENCION PRIMARIA | 2009年 / 41卷 / 12期
关键词：
ELDERLY SUBJECTS; IMMUNOGENICITY; SPLIT; PROTECTION; SAFETY; VIRUS; REACTOGENICITY; PNEUMONIA; AGE;
D O I：
10.1016/j.aprim.2009.06.008
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：695 / 697
页数：3
相关论文
共 50 条
  • [21] EFFECT OF THE ADJUVANT MF59 ON INFLUENZA VACCINATION IN YOUNG AND OLD MICE
    HIGGINS, DA
    LEETUNG, K
    CARLSON, JR
    VANNEST, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 283 - 283
  • [22] Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019-2020 Influenza Season
    Imran, Mahrukh
    Puig-Barbera, Joan
    Ortiz, Justin R.
    Fischer, Lauren
    O'Brien, Dan
    Bonafede, Machaon
    Mansi, James A.
    Boikos, Constantina
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (05):
  • [23] Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden
    Jacob, Jorge
    Biering-Sorensen, Tor
    Holger Ehlers, Lars
    Edwards, Christina H.
    Mohn, Kristin Greve-Isdahl
    Nilsson, Anna
    Hjelmgren, Jonas
    Ma, Wenkang
    Sharma, Yuvraj
    Ciglia, Emanuele
    Mould-Quevedo, Joaquin
    VACCINES, 2023, 11 (04)
  • [24] Comparison of the Immunogenicity and Safety of the Conventional Subunit, MF59-Adjuvanted, and Intradermal Influenza Vaccines in the Elderly
    Bin Seo, Yu
    Choi, Won Suk
    Lee, Jacob
    Song, Joon Young
    Cheong, Hee Jin
    Kim, Woo Joo
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (07) : 989 - 996
  • [25] Trivalent and quadrivalent MF59®-adjuvanted influenza vaccine in young children: A dose- and schedule-finding study
    Della Cioppa, Giovanni
    Vesikari, Timo
    Sokal, Etienne
    Lindert, Kelly
    Nicolay, Uwe
    VACCINE, 2011, 29 (47) : 8696 - 8704
  • [26] The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
    Podda, A
    VACCINE, 2001, 19 (17-19) : 2673 - 2680
  • [27] Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
    De Donato, S
    Granoff, D
    Minutello, M
    Lecchi, G
    Faccini, M
    Agnello, M
    Senatore, F
    Verweij, P
    Fritzell, B
    Podda, A
    VACCINE, 1999, 17 (23-24) : 3094 - 3101
  • [28] Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children
    Knuf, Markus
    Leroux-Roels, Geert
    Rumke, Hans
    Rivera, Luis
    Pedotti, Paola
    Arora, Ashwani Kumar
    Lattanzi, Maria
    Kieninger, Dorothee
    Della Cioppa, Giovanni
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (02) : 358 - 376
  • [29] Safety of MF-59 adjuvanted vaccine for pandemic influenza: Results of the vaccination campaign in an Italian health district
    Cristiani, Cristina
    Tuccori, Marco
    Pepe, Pasquale
    Sarteschi, Alessandro
    Maddalo, Francesco
    Simonini, Gianmarco
    Michi, Paola
    Consigli, Veronica
    Fornai, Matteo
    Antonioli, Luca
    Blandizzi, Corrado
    VACCINE, 2011, 29 (18) : 3443 - 3448
  • [30] Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children
    Dmitri Kazmin
    Elizabeth A. Clutterbuck
    Giorgio Napolitani
    Amanda L. Wilkins
    Andrea Tarlton
    Amber J. Thompson
    Emmanuele Montomoli
    Guilia Lapini
    Smiti Bihari
    Rachel White
    Claire Jones
    Matthew D. Snape
    Ushma Galal
    Ly-Mee Yu
    Rino Rappuoli
    Giuseppe Del Giudice
    Andrew J. Pollard
    Bali Pulendran
    npj Vaccines, 8
12345